about
IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicansMemory T follicular helper CD4 T cellsOropharyngeal Candidiasis in HIV Infection: Analysis of Impaired Mucosal Immune Response to Candida albicans in Mice Expressing the HIV-1 TransgeneMendelian genetics of human susceptibility to fungal infectionTargeting of interleukin-17 in the treatment of psoriasisControl of adaptive immunity by the innate immune systemThe IL-23-IL-17 immune axis: from mechanisms to therapeutic testingExperimental Models of Vaginal Candidiasis and Their Relevance to Human CandidiasisDifferential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1Recombinant Human IFNα-2b Response Promotes Vaginal Epithelial Cells Defense against Candida albicans.Candida albicans Niche Specialization: Features That Distinguish Biofilm Cells from Commensal Cells.Utilization of zebrafish for intravital study of eukaryotic pathogen-host interactions.Animal models for candidiasisPrimary immunodeficiencies underlying fungal infectionsIL-6 as a druggable target in psoriasis: focus on pustular variants.IL-17/Th17 pathway is activated in acne lesionsBeyond canonical inflammasomes: emerging pathways in IL-1-mediated autoinflammatory diseaseDefective IL-17- and IL-22-dependent mucosal host response to Candida albicans determines susceptibility to oral candidiasis in mice expressing the HIV-1 transgene.IL-17A-mediated protection against Acanthamoeba keratitis.The anaphase-promoting complex protein 5 (AnapC5) associates with A20 and inhibits IL-17-mediated signal transduction.Dectin-2 deficiency promotes Th2 response and mucin production in the lungs after pulmonary infection with Cryptococcus neoformans.Tailored immune responses: novel effector helper T cell subsets in protective immunity.Adaptive immunity to fungi.Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis.Candida albicans colonization and dissemination from the murine gastrointestinal tract: the influence of morphology and Th17 immunityAlterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge.Innate Defense against Fungal PathogensSecretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice.Antibodies to Pseudogymnoascus destructans are not sufficient for protection against white-nose syndrome.C/EBPβ Promotes Immunity to Oral Candidiasis through Regulation of β-Defensins.The White-Nose Syndrome Transcriptome: Activation of Anti-fungal Host Responses in Wing Tissue of Hibernating Little Brown Myotis.Basic biology and role of interleukin-17 in immunity and inflammationA Candida albicans Strain Expressing Mammalian Interleukin-17A Results in Early Control of Fungal Growth during Disseminated Infection.Langerhans Cells Suppress CD49a+ NK Cell-Mediated Skin Inflammation.Estradiol Enhances CD4+ T-Cell Anti-Viral Immunity by Priming Vaginal DCs to Induce Th17 Responses via an IL-1-Dependent PathwaySequential Dysfunction and Progressive Depletion of Candida albicans-Specific CD4 T Cell Response in HIV-1 Infection.Neutrophils Do Not Express IL-17A in the Context of Acute Oropharyngeal Candidiasis.Delinking CARD9 and IL-17: CARD9 Protects against Candida tropicalis Infection through a TNF-α-Dependent, IL-17-Independent Mechanism.Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaquesSingle-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity.
P2860
Q26799351-3560164A-5550-4870-923F-4B2422840FFAQ26829047-DB3DBC9C-7B68-434D-AC88-8D4D7AA9AD7CQ27005798-CE95EC5B-4523-408B-A6B9-4989AFEAF0F3Q27022250-6A67B919-7712-4EAD-9E2C-99DA2F610285Q27026324-F8419B2E-F83D-4F60-8B44-26D4E8D36CEAQ27026513-29E44BA7-03DE-435E-B021-8179A94450BDQ27687800-F69DEF69-3478-48F1-B90D-C9B98AF4DFB4Q28077299-A6403734-8CC7-41AB-8312-84A5CF324335Q28486281-23C39056-DF24-4437-88CD-E846C4F3EC53Q33580895-0A3412BE-A316-4084-9EB6-9F7E66074617Q33603993-DA544DD1-E7CF-49B4-AF25-1C82DF376FBDQ33638779-A0C04DBA-7B81-4E2B-9C7C-08865C888435Q33870482-503D99D9-0D7E-4202-A0C9-F5F476A0A5A9Q33902831-3DD45DA7-E9B1-4059-A4C8-FED8C85FB124Q34003280-22BAE0E2-5F9B-4D21-917A-AA81242F62A9Q34083589-D735E518-050D-4B37-85FB-E9ECBABDF6D6Q34307642-25EC33F0-FED5-47DF-BBA0-DE19DEB8AAECQ34423476-A1364EB3-DBCD-48B6-B8F3-13623D9B2681Q34810412-8FCD17F9-D3E5-4D3D-A43E-0C9711F41A0CQ34906387-DBE39CD4-789D-4A8B-B1EA-ED4CF48E18D1Q34955594-71CAA921-6C73-4171-950D-F2DD95383F5FQ35105613-87DABDD7-EF51-4FFD-ACE0-2F081F875586Q35164257-AAD60870-A068-4448-B6DE-7BACB6D46EC4Q35301398-9D1997A6-19F5-44CE-BCB8-727F7E6BA6F6Q35535803-103C9AEC-7F99-495A-8446-87555502B14AQ35546243-51B5A7A8-3D50-4B5E-8172-5D51D3E58BABQ35589587-54AE7EBA-4233-4D1D-968C-C27A0EA0F315Q35650359-D1F0EFF5-C418-41E0-8766-C1223FCF7EF4Q35705655-93C540E0-5BB4-4529-A27F-BC9C66EF0A70Q35758463-40D980C8-FC91-4093-9D34-BD5AF4733BE7Q35794927-7AAEAF08-2B10-4B70-BDE7-F8A13FCD3121Q35932948-A042A90D-13A2-4AC1-9018-6B035D07F204Q35947439-3A063B4A-D03E-4BBD-84BF-85EB48A19F68Q35988800-8950F7E7-299C-4B17-A7B7-45E8188A16A0Q36009231-7934B2C7-541B-4399-9828-4C798B5763A8Q36046570-153C6F42-FCA7-4E91-9388-F2A459362DFAQ36096377-D94E1B28-9DC5-4FBC-A075-4253B5860A41Q36116759-32B21DF4-D353-4232-82FA-161093DFA4E7Q36335882-5B32AE0C-27A6-474E-A691-E40726169634Q36352374-C816B120-265F-4CB4-87CB-B658F8D6C6E7
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Th17 cells in immunity to Candida albicans.
@en
type
label
Th17 cells in immunity to Candida albicans.
@en
prefLabel
Th17 cells in immunity to Candida albicans.
@en
P2860
P1433
P1476
Th17 cells in immunity to Candida albicans.
@en
P2093
Nydiaris Hernández-Santos
Sarah L Gaffen
P2860
P304
P356
10.1016/J.CHOM.2012.04.008
P577
2012-05-01T00:00:00Z